About this file

This document provides a notice of intent to sole source a contract from the Department of Veterans Affairs Network Contracting Office 2. The VA intends to award a one-year purchase order to Progenics Pharmaceuticals, Inc. through their sole Northeast Distributor Sofie, for deliveries of the Pylarify prostate-specific membrane antigen positive emission tomography prostate cancer imaging agent. Deliveries will be made to VA medical facilities in New York Harbor, New Jersey, Northport and the Bronx. Pylarify is a radioactive diagnostic agent used to detect prostate cancer metastasis or recurrence. Responses to the notice will be considered until October 28, 2021 to determine sources for future procurements. The applicable NAICS code is 325412 for pharmaceutical preparation manufacturing and the FSC is 6505 for drugs and biologicals.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Special Notice Special Notice

SUBJECT*
Intent to sole source Pylarify PSMA PET prostate cancer imaging agent- VISN 2 Down State

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
10468-3904
SOLICITATION NUMBER*
36C24222Q0053
ARCHIVE
60 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N
PRODUCT SERVICE CODE*
6505
NAICS CODE*
325413
CONTRACTING OFFICE ADDRESS
Department of Veterans Affairs

Network Contracting Office 2 James J. Peters VA Medical Center 130 West Kingsbridge Road Bronx NY 10468-3904

POINT OF CONTACT*

Tina.Cavalieri@va.gov Tina M Cavalieri tina.cavalieri@va.gov

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

NOTICE OF INTENT TO SOLE SOURCE

Department of Veterans Affairs (VA) Network Contracting Office 2 (NCO 2) hereby gives notice of the Government’s intent to sole source a purchase order for a period of performance of 1 year with Progenics Pharmaceuticals, Inc. through their sole Northeast Distributor Sofie, for Pylarify prostate-specific membrane antigen (PSMA) positive emission tomography (PET) prostate cancer imaging agent deliveries at the VISN 2 Down State Facilities, New York Harbor, New Jersey, Northport and Bronx VAMC’s.

Pylarify, (Piflufolastat F-18), is a radioactive diagnostic agent indicated for positive emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. It can be used for men with suspected metastasis who are candidates for initial definitive therapy or those with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.

It is the Government’s belief that the proposed candidate is the only provider of PSMA PET prostate cancer imaging agent that can meet the agency’s needs. The applicable North American Industry Classification System (NAICS) code is 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,250 employees and the Federal Supply Code (FSC) is 6505(Drugs and Biologicals).

This notice of intent is not a request for competitive quotes and no solicitation will be made available. Any response received NLT October 28, 2021 at 3PM will be considered for the purposed of determining sources for future procurements Tina.Cavalieri@va.gov. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. A determination by the Government not to compete the proposed acquisition based upon responses of this notice is solely within the discretion of the Government. No telephone inquiries will be accepted.

THIS SYNOPSIS DOES NOT COMMIT THE GOVERNMENT TO CONTRACT FOR ANY SUPPLY OR SERVICE. THE GOVERNMENT WILL NOT PAY FOR ANY INFORMATION OR ADMINISTRATIVE COSTS INCURRED IN RESPONSE TO THIS SYNOPSIS.

This will be the only notice of the Government’s intent to solicit, negotiate, and award to one source to satisfy this requirement.

*= Required Field
Special Notice

Special Notice

File details come from the government source that posted it. Updated .